TABLE 2.
Effect of NMMA on cytokine inhibition of T. gondii growth in murine astrocytes
| Treatment | Inhibition of T. gondii growth (% of control)a
|
|
|---|---|---|
| Medium only | Cytokines + NMMA | |
| IFN-γ, IL-1 | 22.4 ± 3.1 | 24.7 ± 1.1 |
| IFN-γ, IL-6 | 20.4 ± 2.3 | 21.0 ± 0.8 |
| IFN-γ, IL-1, IL-6 | 18.2 ± 1.5 | 15.2 ± 4.1 |
| IFN-γ, TNF-α | 23.3 ± 3.7 | 16.6 ± 2.5 |
| IFN-γ, TNF-α, IL-6 | 14.3 ± 2.9 | 16.8 ± 2.5 |
Mean ± standard deviation of three separate experiments for astrocyte cultures treated with IFN-γ (100 U/ml), IL-1 (1 ng/ml), IL-6 (100 U/ml), and TNF-α (100 U/ml), in the presence or absence of NMMA (400 μM), and for control cultures incubated in medium alone. Cells were incubated with cytokines for 72 h prior to infection, and NMMA was added at the time of cytokine addition; [3H]uracil (2.5 μCi/ml) was added 2 h after infection, and cells were harvested 48 h later. No endotoxin contamination was detected in any of the cultures.